Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Phase II evaluation of thalidomide in patients with metastatic breast cancer
S M Baidas, E P Winer, G F Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
L Welles, M W Saville, J Lietzau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2001
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer
W D Figg, W Dahut, P Duray, et al.
Cancer
|
December 18, 2001
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck
J E Tseng, B S Glisson, F R Khuri, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Phase II evaluation of thalidomide in patients with metastatic breast cancer
S M Baidas, E P Winer, G F Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
L Welles, M W Saville, J Lietzau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2001
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer
W D Figg, W Dahut, P Duray, et al.
Cancer
|
December 18, 2001
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck
J E Tseng, B S Glisson, F R Khuri, et al.
Page
of 6